Changes in endocrinological functions in hemodialysis patients associated with improvements in anemia after recombinant human erythropoietin therapy.
Akizawa
T
T
Department of Internal Medicine, Showa University Fujigaoka Hospital, Yokohama, Japan.
Kinugasa
E
E
Nakayama
F
F
Takahashi
T
T
Koshikawa
S
S
Shimizu
N
N
D000328:Adult; D000740:Anemia / Q000503:physiopathology* / Q000628:therapy; D004702:Endocrine Glands / Q000502:physiology*; D004921:Erythropoietin / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D012739:Gonadal Steroid Hormones / Q000097:blood; D006400:Hematocrit; D006801:Humans; D008297:Male; D008875:Middle Aged; D010907:Pituitary Hormones / Q000097:blood; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use; D006435:Renal Dialysis / Q000009:adverse effects*; D012723:Sex; D012737:Sex Factors
D012739:Gonadal Steroid Hormones; D010907:Pituitary Hormones; D011994:Recombinant Proteins; D004921:Erythropoietin